Skip to content

Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses

A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00797498
Acronym
SI01
Enrollment
174
Registered
2008-11-25
Start date
2006-08-31
Completion date
2015-12-31
Last updated
2017-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancers of Nasal Cavity, Cancers of Paranasal Sinuses

Keywords

Nasal Cavity, Paranasal Sinuses, Proton Radiation, Outcomes

Brief summary

The purpose of this study is to collect information from a questionnaire and medical records to see what effects proton radiation has on cancer and collect and analyze morbidity outcomes: incidence of Xerostomia (dry mouth) and tumor control.

Detailed description

The study is non interventional outcomes protocol designed to collect information from a questionnaire and medical records to see what effects proton radiation has on cancer and collect and analyze morbidity outcomes: incidence of Xerostomia (dry mouth) and tumor control.

Interventions

All of the tests, procedures and treatments may be considered standard of care for someone with this type of cancer, except for the Xerostomia Questionnaire.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cancer of nasal cavity and/or paranasal sinuses. * Will receive treatment with proton radiation.

Exclusion criteria

* Evidence of distant metastasis. * Previous radiation for head and neck cancer.

Design outcomes

Primary

MeasureTime frame
Grade 3 or higher of xerostomia Incidence of XerostomiaOne year after the end of radiation therapy.

Secondary

MeasureTime frame
Collect and analyze tumor control outcomesWhen each patient has been followed for a minimum of 12 months with final analysis after 24 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026